pravastatin has been researched along with Hepatitis C, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchet, M; Labonté, P; Le, QT; Seidah, NG | 1 |
1 other study(ies) available for pravastatin and Hepatitis C, Chronic
| Article | Year |
|---|---|
Statins can exert dual, concentration dependent effects on HCV entry in vitro.
Topics: Claudin-1; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-alpha; Membrane Proteins; Membrane Transport Proteins; Polyethylene Glycols; Pravastatin; Receptors, LDL; Ribavirin | 2016 |